Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services symbols : Crl save search
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.0%
H: 0.0%
C: -1.52%
animal alternative
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -1.85%
H: 1.02%
C: -1.12%
conference
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.48%
H: 0.0%
C: 0.0%
for
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.93%
H: 0.36%
C: -0.05%
rare disease collaboration therapeutics therapy
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.06%
H: 0.81%
C: -0.88%
Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) Advancements & Future Forecasts through 2030
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
CRYO | $0.0001 0.0% 19K
|
Information
| Email alert
Add to watchlist
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
| Email alert
Add to watchlist
CTXR | $0.8055 -1.31% -2.02% 6.1M
|
Health Technology
| Email alert
Add to watchlist
SNNUF | News | $11.93 -1.16% -1.12% 8
|
Health Technology
| Email alert
Add to watchlist
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.68%
H: 1.71%
C: 1.27%
extension therapy
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.0%
H: 1.41%
C: -0.26%
collaboration therapeutics therapy
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
Published: 2024-02-29 (Crawled : 07:00) - prnewswire.com
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.41%
H: 0.74%
C: -1.39%
cmc agreement
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Published: 2024-02-21 (Crawled : 18:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -1.05%
H: 2.05%
C: 1.98%
agreement
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
Published: 2024-02-20 (Crawled : 13:30) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.86%
H: 0.44%
C: -1.61%
Bioburden Testing Market worth $2.59 billion by 2031 Owing To Increasing Demand for Quality Assurance and Safety Measures - Exclusive Report by Coherent Market Insights
Published: 2024-02-15 (Crawled : 17:00) - prnewswire.com
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -1.24%
H: 1.61%
C: 1.37%
report market
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
Published: 2024-02-14 (Crawled : 14:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 3.0%
H: 8.18%
C: 8.05%
results
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.4%
H: 2.63%
C: 2.35%
first test rapid
Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing Demand for Personalized Medicine
Published: 2024-01-16 (Crawled : 15:00) - prnewswire.com
LH M | $199.45 -0.26% 0.0% 770K
|
Health Services
|
| O: -0.69%
H: 0.46%
C: -0.08%
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -1.58%
H: 0.17%
C: -0.83%
CTLT | $55.8 -0.29% 0.0% 1.1M
|
Health Technology
|
| O: -0.63%
H: 0.97%
C: 0.82%
ICLR | $291.82 -0.07% -0.1% 500K
|
Health Technology
|
| O: -1.27%
H: 1.62%
C: -0.33%
growing therapeutics advanced market
Clinical Trial Services Market to Exhibit Significant Growth at 6.11% CAGR, Garnering $72.54 Billion by 2030, with North America Leading the Industry as Demand for Innovative Therapies Rises, States Kings Research
Published: 2023-12-15 (Crawled : 15:00) - prnewswire.com
LH M | $199.45 -0.26% 0.0% 770K
|
Health Services
|
| O: -0.77%
H: 0.63%
C: -0.84%
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.02%
H: 0.73%
C: 0.66%
MEDP | $374.32 -2.12% -2.19% 220K
|
Commercial Services
|
| O: 0.24%
H: 1.67%
C: 0.27%
ICLR | $291.82 -0.07% -0.1% 500K
|
Health Technology
|
| O: 0.6%
H: 0.54%
C: -0.23%
america services research trial growth market
Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
Published: 2023-12-12 (Crawled : 14:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: 0.32%
H: 1.83%
C: 1.72%
drug services cancer agreement therapy
Visgenx and Charles River Announce Expansion of Gene Therapy Manufacturing Alliance
Published: 2023-12-07 (Crawled : 11:00) - prnewswire.com
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.19%
H: 1.65%
C: 1.23%
expansion therapy
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.26%
H: 1.53%
C: 0.53%
genetic collaboration therapy kids
Charles River Laboratories to Present at Evercore ISI Investor Conference - November 27, 2023
Published: 2023-11-27 (Crawled : 14:30) - biospace.com/
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.43%
H: 0.92%
C: -0.69%
conference
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.